Evidence map›Paper›PMID 34878302›Full record

ArticleMicrobiology spectrum2021

Serotypes and Clonal Composition of Streptococcus pneumoniae Isolates Causing IPD in Children and Adults in Catalonia before 2013 to 2015 and after 2017 to 2019 Systematic Introduction of PCV13.

A Redin, P Ciruela, M F de Sevilla, F Gomez-Bertomeu, S Gonzalez-Peris, M A Benitez, G Trujillo, A Diaz, E Jou, C Izquierdo and 12 more

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. mSphere · 2025
    Observational
  3. Observational
  4. Comparative Genotyping of Malaysian Clinical Isolates ofThe Malaysian journal of medical sciences : MJMS · 2025
    Article
  5. Article
  6. Invasive disease caused simultaneously by two different serotypes of Streptococcus pneumoniae: a microbiological appreciation.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 15 institutions in 2 countries.

A RedinInstitut de Recerca Sant Joan de Deu, Hospital Sant Joan de Deu, Barcelona, Spain.
P CiruelaCIBER de Epidemiologia y Salud Publica (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.
M F de SevillaInstitut de Recerca Sant Joan de Deu, Hospital Sant Joan de Deu, Barcelona, Spain.
F Gomez-BertomeuHospital Universitari Joan XXIII, Tarragona, Spain.
S Gonzalez-PerisHospital Universitari Vall d'Hebron, Barcelona, Spain.
M A BenitezHospital comarcal Alt Penedes, Barcelona, Spain.
G TrujilloXarxa Assitencial Universitària de Manresa, Manresa, Spain.
A DiazHospital de Nens, Barcelona, Spain.
E JouHospital Residència Sant Camil, Sant Pere de Ribes, Spain.
C IzquierdoAgencia de Salut Publica de Catalunya (ASPCAT), Generalitat de Catalunya, Barcelona, Spain.
M O Perez-MorenoHospital de Tortosa Verge de la Cinta, Tortosa, Spain.
F Moraga-LlopHospital Universitari Vall d'Hebron, Barcelona, Spain.
M OlsinaHospital Universitari General de Catalunya, Sant Cugat, Spain.
B VinadoHospital Universitari Vall d'Hebron, Barcelona, Spain.
E SanfeliuHospital Sant Jaume d'Olot, Olot, Spain.
A GarciaConsorci del Laboratori Intercomarcal de l'Alt Penedès, l'Anoia i el Garraf, Barcelona, Spain.
S Gonzalez-di LauroConsorci del Laboratori Intercomarcal de l'Alt Penedès, l'Anoia i el Garraf, Barcelona, Spain.
J J Garcia-GarciaInstitut de Recerca Sant Joan de Deu, Hospital Sant Joan de Deu, Barcelona, Spain.
A DominguezCIBER de Epidemiologia y Salud Publica (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.
R Sa-LeaoInstituto de Tecnologia Química e Biológica, Oeiras, Portugal.ORCID 0000-0001-9804-827X
C Muñoz-AlmagroInstitut de Recerca Sant Joan de Deu, Hospital Sant Joan de Deu, Barcelona, Spain.
Catalan Study Group of Invasive Pneumococcal Disease
Hospital Sant Joan de Déu Barcelona · ESVall d'Hebron Hospital Universitari · ESGeneralitat de Catalunya · ESAlthaia · ESConsorci Sanitari Garraf · ESHospital Comarcal de Inca · ESHospital de Nens de Barcelona · ESHospital de Sant Joan Despí Moisès Broggi · ESHospital d'Igualada · ESHospital General de Catalunya · ESHospital Sant Jaume de Calella · ESHospital Universitari de Tortosa Verge de la Cinta · ESHospital Universitari Joan XXIII de Tarragona · ESInstituto de Biologia Experimental e Tecnológica · PTInstituto de Salud Carlos III · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The goal of this study was to investigate the distribution of serotypes and clonal composition of Streptococcus pneumoniae isolates causing invasive pneumococcal disease (IPD) in Catalonia, before and after systematic introduction of PCV13. Pneumococcal strains isolated from normally sterile sites obtained from patients of all ages with IPD received between 2013 and 2019 from 25 health centers of Catalonia were included. Two study periods were defined: presystematic vaccination period (2013 and 2015) and systematic vaccination period (SVP) (2017 to 2019). A total of 2,303 isolates were analyzed. In the SVP, there was a significant decrease in the incidence of IPD cases in children 5 to 17 years old (relative risk [RR] 0.61; 95% confidence interval [CI] 0.38 to 0.99), while there was a significant increase in the incidence of IPD cases in 18- to 64-year-old adults (RR 1.33; 95% CI 1.16 to 1.52) and adults over 65 years old (RR 1.23; 95% CI 1.09 to 1.38). Serotype 8 was the major emerging serotype in all age groups except in 5- to 17-year-old children. In children younger than 5 years old, the main serotypes in SVP were 24F, 15A, and 3, while in adults older than 65 years they were serotypes 3, 8, and 12F. A significant decrease in the proportions of clonal complexes CC156, CC191, and ST306 and an increase in those of CC180, CC53, and CC404 were observed. A steady decrease in the incidence of IPD caused by PCV13 serotypes indicates the importance and impact of systematic vaccination. The increase of non-PCV13 serotypes highlights the need to expand serotype coverage in future vaccines and rethink vaccination programs for older adults.

Indexed as

SerogroupAdolescentAdultAgedAged, 80 and overChildChild, PreschoolFemaleHumansInfantInfant, NewbornMaleMiddle AgedPneumococcal InfectionsPneumococcal VaccinesPolysaccharides, Bacterial13-valent pneumococcal vaccinePneumococcal VaccinesPolysaccharides, Bacterialclonesinvasive pneumococcal diseasepneumococcal conjugate vaccinesserotypesStreptococcus pneumoniae

Identifiers

PMID34878302
PMCPMC8653838
OpenAlexW4200359447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.